Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011, Article ID 464916, 15 pages
http://dx.doi.org/10.1155/2011/464916
Review Article

One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor

1Molecular Oncology, Department of Obstetrics and Gynecology, University of Leipzig, Semmelweisstr. 14, 04103 Leipzig, Germany
2Medical Biochemistry and Molecular Biology, University of Saarland, Medical Center, Building 44, 66421 Homburg, Germany

Received 21 September 2010; Accepted 17 January 2011

Academic Editor: Noel F. Lowndes

Copyright © 2011 Levin Böhlig and Karen Rother. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Talos and U. M. Moll, “Role of the p53 family in stabilizing the genome and preventing polyploidization,” Advances in Experimental Medicine and Biology, vol. 676, pp. 73–91, 2010. View at Google Scholar
  2. D. P. Lane and L. V. Crawford, “T antigen is bound to a host protein in SV40 transformed cells,” Nature, vol. 278, no. 5701, pp. 261–263, 1979. View at Google Scholar · View at Scopus
  3. D. I. H. Linzer and A. J. Levine, “Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40 transformed cells and uninfected embryonal carcinoma cells,” Cell, vol. 17, no. 1, pp. 43–52, 1979. View at Google Scholar · View at Scopus
  4. B. Vogelstein, D. Lane, and A. J. Levine, “Surfing the p53 network,” Nature, vol. 408, no. 6810, pp. 307–310, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. L. A. Donehower, M. Harvey, B. L. Slagle et al., “Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours,” Nature, vol. 356, no. 6366, pp. 215–221, 1992. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. Ventura, D. G. Kirsch, M. E. McLaughlin et al., “Restoration of p53 function leads to tumour regression in vivo,” Nature, vol. 445, no. 7128, pp. 661–665, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. W. Xue, L. Zender, C. Miething et al., “Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas,” Nature, vol. 445, no. 7128, pp. 656–660, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. W. S. El-Deiry, S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein, “Definition of a consensus binding site for p53,” Nature Genetics, vol. 1, no. 1, pp. 45–49, 1992. View at Google Scholar · View at Scopus
  9. G. Farmer, J. Colgan, Y. Nakatani, J. L. Manley, and C. Prives, “Functional interaction between p53, the TATA-binding protein (TBP), and TBP-associated factors in vivo,” Molecular and Cellular Biology, vol. 16, no. 8, pp. 4295–4304, 1996. View at Google Scholar · View at Scopus
  10. X. Liu, C. W. Miller, P. H. Koeffler, and A. J. Berk, “The p53 activation domain binds the TATA box-binding polypeptide in holo-TFIID, and a neighboring p53 domain inhibits transcription,” Molecular and Cellular Biology, vol. 13, no. 6, pp. 3291–3300, 1993. View at Google Scholar · View at Scopus
  11. H. Lu and A. J. Levine, “Human TAF(II)31 protein is a transcriptional coactivator of the p53 protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 11, pp. 5154–5158, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Miyashita and J. C. Reed, “Tumor suppressor p53 is a direct transcriptional activator of the human bax gene,” Cell, vol. 80, no. 2, pp. 293–299, 1995. View at Google Scholar · View at Scopus
  13. W. S. El-Deiry, T. Tokino, V. E. Velculescu et al., “WAF1, a potential mediator of p53 tumor suppression,” Cell, vol. 75, no. 4, pp. 817–825, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Hermeking, C. Lengauer, K. Polyak et al., “14-3-3σ is a p53-regulated inhibitor of G2/M progression,” Molecular Cell, vol. 1, no. 1, pp. 3–11, 1997. View at Google Scholar · View at Scopus
  15. J. Ho and S. Benchimol, “Transcriptional repression mediated by the p53 tumour suppressor,” Cell Death and Differentiation, vol. 10, no. 4, pp. 404–408, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. C. Koumenis, R. Alarcon, E. Hammond et al., “Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation,” Molecular and Cellular Biology, vol. 21, no. 4, pp. 1297–1310, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. T. Riley, E. Sontag, P. Chen, and A. Levine, “Transcriptional control of human p53-regulated genes,” Nature Reviews Molecular Cell Biology, vol. 9, no. 5, pp. 402–412, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. M. Shi, D. Liu, B. Shen, and N. Guo, “Helpers of the cellular gatekeeper-miRNAs dance in P53 network,” Biochimica et Biophysica Acta, vol. 1805, no. 2, pp. 218–225, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. K. H. Vousden and C. Prives, “Blinded by the light: the growing complexity of p53,” Cell, vol. 137, no. 3, pp. 413–431, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. D. Menendez, A. Inga, and M. A. Resnick, “The expanding universe of p53 targets,” Nature Reviews Cancer, vol. 9, no. 10, pp. 724–737, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. B. Wang, Z. Xiao, and EE. C. Ren, “Redefining the p53 response element,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 34, pp. 14373–14378, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. R. A. Johnson, T. A. Ince, and K. W. Scotto, “Transcriptional repression by p53 through direct binding to a novel DNA element,” Journal of Biological Chemistry, vol. 276, no. 29, pp. 27716–27720, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. S. Godar, T. A. Ince, G. W. Bell et al., “Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression,” Cell, vol. 134, no. 1, pp. 62–73, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. J. Marks, Z. Saifudeen, S. Dipp, and S. S. El-Dahr, “Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter,” Journal of Biological Chemistry, vol. 278, no. 36, pp. 34158–34166, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. K. C. Lee, A. J. Crowe, and M. C. Barton, “p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding,” Molecular and Cellular Biology, vol. 19, no. 2, pp. 1279–1288, 1999. View at Google Scholar · View at Scopus
  26. D. S. Wilkinson, W. W. Tsai, M. A. Schumacher, and M. C. Barton, “Chromatin-bound p53 anchors activated Smads and the mSin3A corepressor to confer transforming growth factor β-mediated transcription repression,” Molecular and Cellular Biology, vol. 28, no. 6, pp. 1988–1998, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. D. van Bodegom, W. Roessingh, A. Pridjian, and S. S. El Dahr, “Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter,” Biochimica et Biophysica Acta, vol. 1799, no. 7, pp. 502–509, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. A. Zaky, C. Busso, T. Izumi et al., “Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage,” Nucleic Acids Research, vol. 36, no. 5, pp. 1555–1566, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. S. A. Innocente and J. M. Lee, “p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription,” FEBS Letters, vol. 579, no. 5, pp. 1001–1007, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. ST. Clair, L. Giono, S. Varmeh-Ziaie et al., “DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter,” Molecular Cell, vol. 16, no. 5, pp. 725–736, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. C. Imbriano, A. Gurtner, F. Cocchiarella et al., “Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G/M promoters,” Molecular and Cellular Biology, vol. 25, no. 9, pp. 3737–3751, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. K. Krause, U. Haugwitz, M. Wasner, M. Wiedmann, J. Mössner, and K. Engeland, “Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73,” Biochemical and Biophysical Research Communications, vol. 284, no. 3, pp. 743–750, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. I. Manni, G. Mazzaro, A. Gurtner et al., “NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G arrest,” Journal of Biological Chemistry, vol. 276, no. 8, pp. 5570–5576, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. V. Basile, R. Mantovani, and C. Imbriano, “DNA damage promotes histone deacetylase 4 nuclear localization and repression of G/M promoters, via p53 C-terminal lysines,” Journal of Biological Chemistry, vol. 281, no. 4, pp. 2347–2357, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. G. Le Gac, P. O. Estève, C. Ferec, and S. Pradhan, “DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (cytosine-5) methyltransferase,” Journal of Biological Chemistry, vol. 281, no. 34, pp. 24161–24170, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. K. Löhr, C. Möritz, A. Contente, and M. Dobbelstein, “p21/CDKN1A mediates negative regulation of transcription by p53,” Journal of Biological Chemistry, vol. 278, no. 35, pp. 32507–32516, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. J. Bargonetti, A. Chicas, D. White, and C. Prives, “p53 represses Sp1 DNA binding and HIV-LTR directed transcription,” Cellular and Molecular Biology, vol. 43, no. 7, pp. 935–949, 1997. View at Google Scholar · View at Scopus
  38. W. H. Hoffman, S. Biade, J. T. Zilfou, J. Chen, and M. Murphy, “Transcriptional repression of the anti-apoptotic survivin gene by wild type p53,” Journal of Biological Chemistry, vol. 277, no. 5, pp. 3247–3257, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. D. Raj, T. Liu, G. Samadashwily, F. Li, and D. Grossman, “Survivin repression by p53, Rb and E2F2 in normal human melanocytes,” Carcinogenesis, vol. 29, no. 1, pp. 194–201, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. Y. Jiang, H. I. Saavedra, M. P. Holloway, G. Leone, and R. A. Altura, “Aberrant regulation of survivin by the RB/E2F family of proteins,” Journal of Biological Chemistry, vol. 279, no. 39, pp. 40511–40520, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. P. Dasgupta, R. Kinkade, B. Joshi, C. DeCook, E. Haura, and S. Chellappan, “Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 16, pp. 6332–6337, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. N. H. Nabilsi, R. R. Broaddus, and D. S. Loose, “DNA methylation inhibits p53-mediated survivin repression,” Oncogene, vol. 28, no. 19, pp. 2046–2050, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. S. D'Souza, H. Xin, S. Walter, and D. Choubey, “The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression,” Journal of Biological Chemistry, vol. 276, no. 1, pp. 298–305, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. P. S. Kho, Z. Wang, L. Zhuang et al., “p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis,” Journal of Biological Chemistry, vol. 279, no. 20, pp. 21183–21192, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. C. Li, M. Lin, and J. Liu, “Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis,” Oncogene, vol. 23, no. 58, pp. 9336–9347, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. C. Arias-Lopez, I. Lazaro-Trueba, P. Kerr et al., “p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene,” EMBO Reports, vol. 7, no. 2, pp. 219–224, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. I. Lazaro-Trueba, C. Arias, and A. Silva, “Double bolt regulation of Rad51 by p53: a role for transcriptional repression,” Cell Cycle, vol. 5, no. 10, pp. 1062–1065, 2006. View at Google Scholar · View at Scopus
  48. W. J. Hsieh, S. C. Hsieh, C. C. Chen, and F. F. Wang, “Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage,” Biochemical and Biophysical Research Communications, vol. 369, no. 2, pp. 567–572, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. G. M. Habib, “p53 regulates Hsp90β during arsenite-induced cytotoxicity in glutathione-deficient cells,” Archives of Biochemistry and Biophysics, vol. 481, no. 1, pp. 101–109, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. B. Wang, P. Feng, Z. Xiao, and EE. C. Ren, “LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma,” Journal of Hepatology, vol. 50, no. 3, pp. 528–537, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. D. Xu, Q. Wang, A. Gruber et al., “Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells,” Oncogene, vol. 19, no. 45, pp. 5123–5133, 2000. View at Google Scholar · View at Scopus
  52. N. J. G. Webster, J. L. Resnik, D. B. Reichart, B. Strauss, M. Haas, and B. L. Seely, “Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer,” Cancer Research, vol. 56, no. 12, pp. 2781–2788, 1996. View at Google Scholar · View at Scopus
  53. C. Ohlsson, N. Kley, H. Werner, and D. Leroith, “p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1,” Endocrinology, vol. 139, no. 3, pp. 1101–1107, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Zhang, D. Yu, M. Hu et al., “Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression,” Cancer Research, vol. 60, no. 13, pp. 3655–3661, 2000. View at Google Scholar · View at Scopus
  55. T. Suehiro, T. Kaneda, Y. Ikeda, K. Ar II, Y. Kumon, and K. Hashimoto, “Regulation of human glucocorticoid receptor gene transcription by Sp1 and p53,” Molecular and Cellular Endocrinology, vol. 222, no. 1-2, pp. 33–40, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. Y. Sun, Y. Sun, L. Wenger, J. L. Rutter, C. E. Brinckerhoff, and H. S. Cheung, “p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression,” Journal of Biological Chemistry, vol. 274, no. 17, pp. 11535–11540, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Sun, X. R. Zeng, L. Wenger, G. S. Firestein, and H. S. Cheung, “p53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex,” Journal of Cellular Biochemistry, vol. 92, no. 2, pp. 258–269, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. K. Krause, M. Wasner, W. Reinhard et al., “The tumour suppressor protein p53 can repress transcription of cyclin B,” Nucleic Acids Research, vol. 28, no. 22, pp. 4410–4418, 2000. View at Google Scholar · View at Scopus
  59. M. S. Jung, J. Yun, H. D. Chae et al., “p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor,” Oncogene, vol. 20, no. 41, pp. 5818–5825, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. J. C. Labbe, M. G. Lee, P. Nurse, A. Picard, and M. Doree, “Activation at M-phase of a protein kinase encoded by a starfish homologue of the cell cycle control gene cdc2,” Nature, vol. 335, no. 6187, pp. 251–254, 1988. View at Google Scholar · View at Scopus
  61. J. Yun, H. D. Chae, H. E. Choy et al., “p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor,” Journal of Biological Chemistry, vol. 274, no. 42, pp. 29677–29682, 1999. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Matsui, Y. Katsuno, T. Inoue et al., “Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y,” Journal of Biological Chemistry, vol. 279, no. 24, pp. 25093–25100, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. Y. Zhou, K. R. Mehta, A. P. Choi, S. Scolavino, and X. Zhang, “DNA damage-induced inhibition of securin expression is mediated by p53,” Journal of Biological Chemistry, vol. 278, no. 1, pp. 462–470, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. A. A. Joshi, Z. Wu, R. F. Reed, and D. P. Suttle, “Nuclear factor-Y binding to the topoisomerase IIα promoter is inhibited by both the p53 tumor suppressor and anticancer drugs,” Molecular Pharmacology, vol. 63, no. 2, pp. 359–367, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. Q. Wang, G. P. Zambetti, and D. P. Suttle, “Inhibition of DNA topoisomerase IIα gene expression by the p53 tumor suppressor,” Molecular and Cellular Biology, vol. 17, no. 1, pp. 389–397, 1997. View at Google Scholar · View at Scopus
  66. N. Zhu, L. Gu, H. W. Findley, and M. Zhou, “Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53,” Biochemical and Biophysical Research Communications, vol. 335, no. 4, pp. 1272–1279, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. S. N. Agoff, J. Hou, D. I. H. Linzer, and B. Wu, “Regulation of the human hsp70 promoter by p53,” Science, vol. 259, no. 5091, pp. 84–87, 1993. View at Google Scholar · View at Scopus
  68. M. Fritsche, M. Mundt, C. Merkle, R. Jähne, and B. Groner, “P53 suppresses cytokine induced, Stat5 mediated activation of transcription,” Molecular and Cellular Endocrinology, vol. 143, no. 1-2, pp. 143–154, 1998. View at Publisher · View at Google Scholar · View at Scopus
  69. M. V. Blagosklonny, W. G. An, L. Y. Romanova, J. Trepel, T. Fojo, and L. Neckers, “p53 inhibits hypoxia-inducible factor-stimulated transcription,” Journal of Biological Chemistry, vol. 273, no. 20, pp. 11995–11998, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. C. L. Yu, P. Driggers, G. Barrera-Hernandez, S. B. Nunez, J. H. Segars, and S. Y. Cheng, “The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways,” Biochemical and Biophysical Research Communications, vol. 239, no. 2, pp. 617–620, 1997. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Maeda, S. D. Seidel, G. Wei, X. Liu, and F. M. Sladek, “Repression of hepatocyte nuclear factor 4α by tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity,” Molecular Endocrinology, vol. 16, no. 2, pp. 402–410, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Maeda, W. W. Hwang-Verslues, G. Wei et al., “Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4α (HNF4α) gene,” Biochemical Journal, vol. 400, no. 2, pp. 303–313, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. N. Horikoshi, A. Usheva, J. Chen, A. J. Levine, R. Weinmann, and T. Shenk, “Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression,” Molecular and Cellular Biology, vol. 15, no. 1, pp. 227–234, 1995. View at Google Scholar · View at Scopus
  74. D. H. Mack, J. Vartikar, J. M. Pipas, and L. A. Laimins, “Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53,” Nature, vol. 363, no. 6426, pp. 281–283, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. E. Seto, A. Usheva, G. P. Zambetti et al., “Wild-type p53 binds to the TATA-binding protein and represses transcription,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 24, pp. 12028–12032, 1992. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Truant, H. Xiao, C. J. Ingles, and J. Greenblatt, “Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein,” Journal of Biological Chemistry, vol. 268, no. 4, pp. 2284–2287, 1993. View at Google Scholar · View at Scopus
  77. M. Pietrzak and M. Puzianowska-Kuznicka, “p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter,” Biological Chemistry, vol. 389, no. 4, pp. 383–393, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. Y. Wu, J. W. Mehew, C. A. Heckman, M. Arcinas, and L. M. Boxer, “Negative regulation of bcl-2 expression by p53 in hematopoietic cells,” Oncogene, vol. 20, no. 2, pp. 240–251, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. K. Subbaramaiah, N. Altorkil, W. J. Chung, J. R. Mestre, A. Sampat, and A. J. Dannenberg, “Inhibition of cyclooxygenase-2 gene expression by p53,” Journal of Biological Chemistry, vol. 274, no. 16, pp. 10911–10915, 1999. View at Publisher · View at Google Scholar · View at Scopus
  80. N. Ragimov, A. Krauskopf, N. Navot, V. Rotter, M. Oren, and Y. Aloni, “Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif,” Oncogene, vol. 8, no. 5, pp. 1183–1193, 1993. View at Google Scholar · View at Scopus
  81. D. Crighton, A. Woiwode, C. Zhang et al., “p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB,” EMBO Journal, vol. 22, no. 11, pp. 2810–2820, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. G. Farmer, P. Friedlander, J. Colgan, J. L. Manley, and C. Prives, “Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein,” Nucleic Acids Research, vol. 24, no. 21, pp. 4281–4288, 1996. View at Publisher · View at Google Scholar · View at Scopus
  83. A. A. Gridasova and R. W. Henry, “The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding,” Molecular and Cellular Biology, vol. 25, no. 8, pp. 3247–3260, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. C. L. Sadowski, R. W. Henry, S. M. Lobo, and N. Hernandez, “Targeting TBP to a non-TATA box cis-regulatory element: a TBP-containing complex activates transcription from snRNA promoters through the PSE,” Genes and Development, vol. 7, no. 8, pp. 1535–1548, 1993. View at Google Scholar · View at Scopus
  85. A. Mirza, M. McGuirk, T. N. Hockenberry et al., “Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway,” Oncogene, vol. 21, no. 17, pp. 2613–2622, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. K. V. Gurova, O. W. Roklin, V. I. Krivokrysenko et al., “Expression of prostate specific antigen (PSA) is negatively regulated by p53,” Oncogene, vol. 21, no. 1, pp. 153–157, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. J. S. L. Ho, W. Ma, D. Y. L. Mao, and S. Benchimol, “p53-dependent transcriptional repression of c-myc is required for G cell cycle arrest,” Molecular and Cellular Biology, vol. 25, no. 17, pp. 7423–7431, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. S. K. Ogden, K. C. Lee, K. Wernke-Dollries, S. A. Stratton, B. Aronow, and M. C. Barton, “p53 targets chromatin structure alteration to repress alpha-fetoprotein gene expression,” Journal of Biological Chemistry, vol. 276, no. 45, pp. 42057–42062, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. R. Cui, T. T. Nguyen, J. H. Taube, S. A. Stratton, M. H. Feuerman, and M. C. Barton, “Family members p53 and p73 act together in chromatin modification and direct repression of α-fetoprotein transcription,” Journal of Biological Chemistry, vol. 280, no. 47, pp. 39152–39160, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. T. T. Nguyen, K. Cho, S. A. Stratton, and M. C. Barton, “Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene,” Molecular and Cellular Biology, vol. 25, no. 6, pp. 2147–2157, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. D. S. Wilkinson, S. K. Ogden, S. A. Stratton et al., “A direct intersection between p53 and transforming growth factor β pathways targets chromatin modification and transcription repression of the α-fetoprotein gene,” Molecular and Cellular Biology, vol. 25, no. 3, pp. 1200–1212, 2005. View at Publisher · View at Google Scholar · View at PubMed
  92. M. Murphy, J. Ahn, K. K. Walker et al., “Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a,” Genes and Development, vol. 13, no. 19, pp. 2490–2501, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Murphy, A. Hinman, and A. J. Levine, “Wild-type p53 negatively regulates the expression of a microtubule-associated protein,” Genes and Development, vol. 10, no. 23, pp. 2971–2980, 1996. View at Google Scholar · View at Scopus
  94. J. Li, M. Tan, L. Li, D. Pamarthy, T. S. Lawrence, and Y. Sun, “SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing,” Neoplasia, vol. 7, no. 4, pp. 312–323, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. A. C. S. Chun and D. Y. Jin, “Transcriptional regulation of mitotic checkpoint gene MAD1 by p53,” Journal of Biological Chemistry, vol. 278, no. 39, pp. 37439–37450, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. P. O. Estève, H. G. Chin, and S. Pradhan, “Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 4, pp. 1000–1005, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. K. Rother, C. Johne, K. Spiesbach et al., “Identification of Tcf-4 as a transcriptional target of p53 signalling,” Oncogene, vol. 23, no. 19, pp. 3376–3384, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. S. A. Amundson, M. Bittner, Y. Chen, J. Trent, P. Meltzer, and A. J. Fornace, “Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses,” Oncogene, vol. 18, no. 24, pp. 3666–3672, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. D. Ginsberg, F. Mechta, M. Yaniv, and M. Oren, “Wild-type p53 can down-modulate the activity of various promoters,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 22, pp. 9979–9983, 1991. View at Google Scholar · View at Scopus
  100. S. Rocha, A. M. Martin, D. W. Meek, and N. D. Perkins, “p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-κB subunit with histone deacetylase 1,” Molecular and Cellular Biology, vol. 23, no. 13, pp. 4713–4727, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. V. Gottifredi, O. Karni-Schmidt, S. Y. Shieh, and C. Prives, “p53 down-regulates CHK1 through p21 and the retinoblastoma protein,” Molecular and Cellular Biology, vol. 21, no. 4, pp. 1066–1076, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  102. H. Zhu, B. D. Chang, T. Uchiumi, and I. B. Roninson, “Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21(WAF1/CIP1/SDI1),” Cell Cycle, vol. 1, no. 1, pp. 59–66, 2002. View at Google Scholar · View at Scopus
  103. S. M. De Toledo, E. I. Azzam, P. Keng, S. Laffrenier, and J. B. Little, “Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, Thymidine Kinace, Topoisomerase IIα, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21(Waf1),” Cell Growth and Differentiation, vol. 9, no. 11, pp. 887–896, 1998. View at Google Scholar
  104. P. M. Flatt, L. J. Tang, C. D. Scatena, S. T. Szak, and J. A. Pietenpol, “p53 regulation of G checkpoint is retinoblastoma protein dependent,” Molecular and Cellular Biology, vol. 20, no. 12, pp. 4210–4223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Mannefeld, E. Klassen, and S. Gaubatz, “B-MYB is required for recovery from the DNA damage-induced G checkpoint in p53 mutant cells,” Cancer Research, vol. 69, no. 9, pp. 4073–4080, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. K. Rother, R. Kirschner, K. Sänger, L. Böhlig, J. Mössner, and K. Engeland, “p53 downregulates expression of the G/S cell cycle phosphatase Cdc25A,” Oncogene, vol. 26, no. 13, pp. 1949–1953, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. A. Vigneron, J. Cherier, B. Barré, E. Gamelin, and O. Coqueret, “The cell cycle inhibitor p21 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression,” Journal of Biological Chemistry, vol. 281, no. 46, pp. 34742–34750, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  108. I. Shats, M. Milyavsky, X. Tang et al., “p53-dependent down-regulation of telomerase is mediated by p21,” Journal of Biological Chemistry, vol. 279, no. 49, pp. 50976–50985, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  109. M. W. Jackson, M. K. Agarwal, J. Yang et al., “p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2,” Journal of Cell Science, vol. 118, no. 9, pp. 1821–1832, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. M. J. Scian, E. H. Carchman, L. Mohanraj et al., “Wild-type p53 and p73 negatively regulate expression of proliferation related genes,” Oncogene, vol. 27, no. 18, pp. 2583–2593, 2008. View at Publisher · View at Google Scholar · View at PubMed
  111. J. W. Harper, G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge, “The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases,” Cell, vol. 75, no. 4, pp. 805–816, 1993. View at Publisher · View at Google Scholar · View at Scopus
  112. S. W. Hiebert, S. P. Chellappan, J. M. Horowitz, and J. R. Nevins, “The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F,” Genes and Development, vol. 6, no. 2, pp. 177–185, 1992. View at Google Scholar · View at Scopus
  113. W. R. Taylor, A. H. Schönthal, J. Galante, and G. R. Stark, “p130/E2F4 binds to and represses the cdc2 promoter in response to p53,” Journal of Biological Chemistry, vol. 276, no. 3, pp. 1998–2006, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  114. D. Spitkovsky, A. Schulze, B. Boye, and P. Jansen-Dürr, “Down-regulation of Cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter,” Cell Growth and Differentiation, vol. 8, no. 6, pp. 699–710, 1997. View at Google Scholar · View at Scopus
  115. G. A. Müller and K. Engeland, “The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription: review article,” FEBS Journal, vol. 277, no. 4, pp. 877–893, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  116. T. Kidokoro, C. Tanikawa, Y. Furukawa, T. Katagiri, Y. Nakamura, and K. Matsuda, “CDC20, a potential cancer therapeutic target, is negatively regulated by p53,” Oncogene, vol. 27, no. 11, pp. 1562–1571, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  117. T. Banerjee, S. Nath, and S. Roychoudhury, “DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling,” Nucleic Acids Research, vol. 37, no. 8, pp. 2688–2698, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  118. J. G. Jackson and O. M. Pereira-Smith, “Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells,” Molecular and Cellular Biology, vol. 26, no. 7, pp. 2501–2510, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  119. S. Polager and D. Ginsberg, “E2F mediates sustained G arrest and down-regulation of Stathmin and AIM-1 expression in response to genotoxic stress,” Journal of Biological Chemistry, vol. 278, no. 3, pp. 1443–1449, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  120. H. Siddiqui, D. A. Solomon, R. W. Gunawardena, Y. Wang, and E. S. Knudsen, “Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition,” Molecular and Cellular Biology, vol. 23, no. 21, pp. 7719–7731, 2003. View at Publisher · View at Google Scholar · View at Scopus
  121. K. B. Spurgers, D. L. Gold, K. R. Coombes et al., “Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression,” Journal of Biological Chemistry, vol. 281, no. 35, pp. 25134–25142, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  122. S. Mahmoudi, S. Henriksson, M. Corcoran, C. Méndez-Vidal, K. G. Wiman, and M. Farnebo, “Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage,” Molecular Cell, vol. 33, no. 4, pp. 462–471, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  123. M. M. Candeias, L. Malbert-Colas, D. J. Powell et al., “p53 mRNA controls p53 activity by managing Mdm2 functions,” Nature Cell Biology, vol. 10, no. 9, pp. 1098–1105, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  124. G. T. Bommer, I. Gerin, Y. Feng et al., “p53-mediated activation of miRNA34 candidate tumor-suppressor genes,” Current Biology, vol. 17, no. 15, pp. 1298–1307, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  125. L. He, X. He, L. P. Lim et al., “A microRNA component of the p53 tumour suppressor network,” Nature, vol. 447, no. 7148, pp. 1130–1134, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  126. V. Tarasov, P. Jung, B. Verdoodt et al., “Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G -arrest,” Cell Cycle, vol. 6, no. 13, pp. 1586–1593, 2007. View at Google Scholar · View at Scopus
  127. T. C. Chang, E. A. Wentzel, O. A. Kent et al., “Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis,” Molecular Cell, vol. 26, no. 5, pp. 745–752, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  128. N. Raver-Shapira, E. Marciano, E. Meiri et al., “Transcriptional activation of miR-34a contributes to p53-mediated apoptosis,” Molecular Cell, vol. 26, no. 5, pp. 731–743, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  129. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. A. Eulalio, E. Huntzinger, and E. Izaurralde, “Getting to the root of miRNA-mediated gene silencing,” Cell, vol. 132, no. 1, pp. 9–14, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  131. D. Baek, J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel, “The impact of microRNAs on protein output,” Nature, vol. 455, no. 7209, pp. 64–71, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  132. M. Selbach, B. Schwanhäusser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky, “Widespread changes in protein synthesis induced by microRNAs,” Nature, vol. 455, no. 7209, pp. 58–63, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  133. H. Guo, N. T. Ingolia, J. S. Weissman, and D. P. Bartel, “Mammalian microRNAs predominantly act to decrease target mRNA levels,” Nature, vol. 466, no. 7308, pp. 835–840, 2010. View at Publisher · View at Google Scholar · View at PubMed
  134. C. J. Braun, X. Zhang, I. Savelyeva et al., “p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest,” Cancer Research, vol. 68, no. 24, pp. 10094–10104, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  135. S. A. Georges, M. C. Biery, S. Y. Kim et al., “Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215,” Cancer Research, vol. 68, no. 24, pp. 10105–10112, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  136. L. Bohlig, M. Friedrich, and K. Engeland, “p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins,” Nucleic Acids Research, vol. 39, no. 2, pp. 440–453, 2011. View at Google Scholar
  137. Y. Takahashi, A. R. R. Forrest, E. Maeno, T. Hashimoto, C. O. Daub, and J. Yasuda, “MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines,” PLoS One, vol. 4, no. 8, Article ID e6677, 2009. View at Publisher · View at Google Scholar · View at PubMed
  138. M. Yamakuchi, C. D. Lotterman, C. Bao et al., “P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 14, pp. 6334–6339, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  139. R. Brosh, R. Shalgi, A. Liran et al., “p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation,” Molecular Systems Biology, vol. 4, Article ID 229, 2008. View at Publisher · View at Google Scholar · View at PubMed
  140. M. Sachdeva, S. Zhu, F. Wu et al., “p53 represses c-Myc through induction of the tumor suppressor miR-145,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 9, pp. 3207–3212, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  141. H. L. Yan, G. Xue, Q. Mei et al., “Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis,” EMBO Journal, vol. 28, no. 18, pp. 2719–2732, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  142. M. Guttman, I. Amit, M. Garber et al., “Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals,” Nature, vol. 458, no. 7235, pp. 223–227, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  143. A. M. Khalil, M. Guttman, M. Huarte et al., “Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 28, pp. 11667–11672, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  144. M. Huarte, M. Guttman, D. Feldser et al., “A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response,” Cell, vol. 142, no. 3, pp. 409–419, 2010. View at Publisher · View at Google Scholar · View at PubMed
  145. B. Wang, Z. Xiao, H. L. Ko, and E. C. Ren, “The p53 response element and transcriptional repression,” Cell Cycle, vol. 9, no. 5, pp. 870–879, 2010. View at Google Scholar · View at Scopus
  146. F. Murray-Zmijewski, E. A. Slee, and X. Lu, “A complex barcode underlies the heterogeneous response of p53 to stress,” Nature Reviews Molecular Cell Biology, vol. 9, no. 9, pp. 702–712, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  147. N. Moskovits, A. Kalinkovich, J. Bar, T. Lapidot, and M. Oren, “p53 attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts,” Cancer Research, vol. 66, no. 22, pp. 10671–10676, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  148. J. Pesch, U. Brehm, C. Staib, and F. Grummt, “Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53,” Journal of Interferon and Cytokine Research, vol. 16, no. 8, pp. 595–600, 1996. View at Google Scholar · View at Scopus
  149. U. Santhanam, A. Ray, and P. B. Sehgal, “Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 17, pp. 7605–7609, 1991. View at Google Scholar · View at Scopus
  150. J. Ahn, M. Murphy, S. Kratowicz, A. Wang, A. J. Levine, and D. L. George, “Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction,” Oncogene, vol. 18, no. 43, pp. 5954–5958, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  151. W. E. Mercer, M. T. Shields, D. Lin, E. Appella, and S. J. Ullrich, “Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 5, pp. 1958–1962, 1991. View at Google Scholar · View at Scopus
  152. L. C. Harris, J. S. Remack, P. J. Houghton, and T. P. Brent, “Wild-type p53 suppresses transcription of the human O6-methylguanine-DNA methyltransferase gene,” Cancer Research, vol. 56, no. 9, pp. 2029–2032, 1996. View at Google Scholar · View at Scopus
  153. V. Iotsova, P. Crépieux, C. Montpellier, V. Laudet, and D. Stehelin, “TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53,” Oncogene, vol. 13, no. 11, pp. 2331–2337, 1996. View at Google Scholar · View at Scopus
  154. K. Rother, Y. Y. Li, K. Tschöp et al., “Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73,” Cell Cycle, vol. 6, no. 7, pp. 853–862, 2007. View at Google Scholar · View at Scopus
  155. K. Rother, M. Dengl, J. Lorenz et al., “Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73,” FEBS Letters, vol. 581, no. 6, pp. 1166–1172, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  156. P. Arizti, L. Fang, I. Park et al., “Tumor suppressor p53 is required to modulate BRCA1 expression,” Molecular and Cellular Biology, vol. 20, no. 20, pp. 7450–7459, 2000. View at Publisher · View at Google Scholar · View at Scopus
  157. T. K. MacLachlan, B. C. Dash, D. T. Dicker, and W. S. El-Deiry, “Repression of BRCA1 through a feedback loop involving p53,” Journal of Biological Chemistry, vol. 275, no. 41, pp. 31869–31875, 2000. View at Google Scholar · View at Scopus
  158. B. Singh, P. G. Reddy, A. Goberdhan et al., “p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas,” Genes and Development, vol. 16, no. 8, pp. 984–993, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  159. S. Sengupta, A. Shimamoto, M. Koshiji et al., “Tumor suppressor p53 represses transcription of RECQ4 helicase,” Oncogene, vol. 24, no. 10, pp. 1738–1748, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  160. T. Criswell, D. Klokov, M. Beman, J. P. Lavik, and D. A. Boothman, “Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein,” Cancer Biology and Therapy, vol. 2, no. 4, pp. 372–380, 2003. View at Google Scholar
  161. X. Luo, Q. He, Y. Huang, and M. S. Sheikh, “Cloning and characterization of a p53 and DNA damage down-regulated gene PIQ that codes for a novel calmodulin-binding IQ motif protein and is up-regulated in gastrointestinal cancers,” Cancer Research, vol. 65, no. 23, pp. 10725–10733, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  162. S. Sohr and K. Engeland, “RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53,” Cell Cycle, vol. 7, no. 21, pp. 3448–3460, 2008. View at Google Scholar · View at Scopus